Medtronic

Company Overview

Medtronic focuses on researching, designing, manufacturing, and supplying diabetes management products for diabetic patients and medical professionals in the U.S. and internationally. Headquarters in Dublin, the company has four operating segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The Diabetes Group develops, manufactures, and markets products and services for managing type 1 and type 2 diabetes. This group has three divisions: Non-Intensive Diabetes Therapies, Intensive Insulin Management, and Diabetes Services and Solutions. These divisions develop, manufacture, and market advanced, integrated diabetes management solutions, including continuous glucose monitoring (CGM) systems, insulin pump therapy, and therapy management software.

The company operates in over 150 countries globally and has an employee base of over 95,000. The company’s products include glucose meters, child and pump therapy products, infusion sets, insulin pump therapy products, evaluation products, remote glucose monitors, and accessories for diabetes.

Financial Highlights (FY 2024)

Company's Business Segments

• Cardiovascular : Cardiac Rhythm & Heart Failure, Structural Heart & Aortic, and Coronary & Peripheral Vascular
• Medical Surgical : Surgical and Respiratory, Acute Care & Monitoring.
• Neuroscience : Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation
• Diabetes : Develops, Manufactures, Markets products and services for the management of Type 1 and Type 2 Diabetes.
• Other Operating Segment : Includes historical operations and ongoing transition agreements from businesses the Company has exited or divested, which primarily includes the Company's Ventilator Product Line and the Renal Care Solutions Business.